<VariationArchive VariationID="1478370" VariationName="NM_000102.4(CYP17A1):c.667-13_667-10del" VariationType="Deletion" Accession="VCV001478370" Version="8" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-06-17" DateCreated="2016-10-09" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1351877" VariationID="1478370">
      <GeneList>
        <Gene Symbol="CYP17A1" FullName="cytochrome P450 family 17 subfamily A member 1" GeneID="1586" HGNC_ID="HGNC:2593" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>10q24.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="102830531" stop="102837413" display_start="102830531" display_stop="102837413" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="104590287" stop="104597289" display_start="104590287" display_stop="104597289" Strand="-" />
          </Location>
          <OMIM>609300</OMIM>
        </Gene>
        <Gene Symbol="CYP17A1-AS1" FullName="CYP17A1 antisense RNA 1" GeneID="102724307" HGNC_ID="HGNC:31671" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>10q24.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="102832676" stop="102834504" display_start="102832676" display_stop="102834504" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_000102.4(CYP17A1):c.667-13_667-10del</Name>
      <CanonicalSPDI>NC_000010.11:102834131:AAAAA:A</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>10q24.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="102834132" stop="102834135" display_start="102834132" display_stop="102834135" variantLength="4" positionVCF="102834131" referenceAlleleVCF="TAAAA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="104593889" stop="104593892" display_start="104593889" display_stop="104593892" variantLength="4" positionVCF="104593888" referenceAlleleVCF="TAAAA" alternateAlleleVCF="T" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.10" sequenceAccession="NC_000010" sequenceVersion="10" change="g.104593890_104593893del" Assembly="GRCh37">
            <Expression>NC_000010.10:g.104593890_104593893del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.11" sequenceAccession="NC_000010" sequenceVersion="11" change="g.102834133_102834136del" Assembly="GRCh38">
            <Expression>NC_000010.11:g.102834133_102834136del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007955.1" sequenceAccession="NG_007955" sequenceVersion="1" change="g.8399_8402del">
            <Expression>NG_007955.1:g.8399_8402del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000102.4" sequenceAccession="NM_000102" sequenceVersion="4" change="c.667-13_667-10del" MANESelect="true">
            <Expression>NM_000102.4:c.667-13_667-10del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1844127277" DB="dbSNP" />
        <XRef Type="Allelic variant" ID="609300.0035" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000102.4(CYP17A1):c.667-13_667-10del AND not provided" Accession="RCV002018992" Version="3">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-06-25" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000102.4(CYP17A1):c.667-13_667-10del AND 17-alpha-hydroxylase/17,20-lyase deficiency, combined complete" Accession="RCV002266080" Version="1">
        <ClassifiedConditionList TraitSetID="457">
          <ClassifiedCondition DB="MedGen" ID="CN042980">17-alpha-hydroxylase/17,20-lyase deficiency, combined complete</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2004-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000102.4(CYP17A1):c.667-13_667-10del AND Congenital adrenal hyperplasia" Accession="RCV002282672" Version="1">
        <ClassifiedConditionList TraitSetID="8584">
          <ClassifiedCondition DB="MedGen" ID="C0001627">Congenital adrenal hyperplasia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-08-10" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000102.4(CYP17A1):c.667-13_667-10del AND Deficiency of steroid 17-alpha-monooxygenase" Accession="RCV003471223" Version="2">
        <ClassifiedConditionList TraitSetID="6417">
          <ClassifiedCondition DB="MedGen" ID="C0268285">Deficiency of steroid 17-alpha-monooxygenase</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-06" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-06" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2016-10-09" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">14715826</ID>
        </Citation>
        <DescriptionHistory Dated="2022-07-17">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-07-17">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="8584" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6254" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Congenital adrenal hyperplasia</ElementValue>
                <XRef ID="HP:0008258" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0018479" DB="MONDO" />
                <XRef ID="237751000" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CAH</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1467" />
                <XRef ID="1467" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2018">
                <URL>https://www.acmg.net/PDFLibrary/CAH-Transition.pdf</URL>
                <CitationText>American College of Medical Genetics ACT SHEET, Transition to Adult Health Care ACT Sheet, Congenital Adrenal Hyperplasia (CAH)</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2009">
                <URL>https://www.acmg.net/PDFLibrary/Elevated-17-OHP-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Congenital Adrenal Hyperplasia (Elevated 17-OHP), 2009</CitationText>
              </Citation>
              <XRef ID="418" DB="Orphanet" />
              <XRef ID="C0001627" DB="MedGen" />
              <XRef ID="MONDO:0018479" DB="MONDO" />
              <XRef Type="primary" ID="HP:0008258" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6417" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="185" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">ADRENAL HYPERPLASIA V</ElementValue>
                <XRef Type="MIM" ID="202110" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">17-alpha-hydroxylase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency</ElementValue>
                <XRef ID="MONDO:0008730" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital adrenal hyperplasia type 5</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Deficiency of steroid 17-alpha-monooxygenase</ElementValue>
                <XRef ID="124220008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">17-alpha-hydroxylase/17,20-lyase deficiency</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1469" />
                <XRef ID="1469" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="90793" DB="Orphanet" />
              <XRef ID="C0268285" DB="MedGen" />
              <XRef ID="MONDO:0008730" DB="MONDO" />
              <XRef Type="MIM" ID="202110" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="457" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="8871" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">17-alpha-hydroxylase/17,20-lyase deficiency, combined complete</ElementValue>
                <XRef ID="MONDO:0800379" DB="MONDO" />
              </Name>
              <XRef ID="CN042980" DB="MedGen" />
              <XRef ID="MONDO:0800379" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="22037" SubmissionDate="2016-10-05" DateLastUpdated="2016-10-09" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="609300.0035_17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED COMPLETE" title="CYP17A1, IVS3AS, 4-BP DEL_17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED COMPLETE" />
        <ClinVarAccession Accession="SCV000022037" DateUpdated="2016-10-09" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2004-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 46,XY American subject with complete 17-alpha-hydroxylase/17,20-lyase deficiency (202110), Costa-Santos et al. (2004) identified homozygosity for a 4-bp deletion, TTTT, near the 3-prime end of intron 3 of the CYP17A1 gene. RNA derived from the TTTT deletion skipped exon 4 entirely, deleting 29 amino acids in-frame; cells expressing the mutant gene had no 17-hydroxylase activity. The diagnosis in the patient had been based on extremely elevated 11-deoxycorticosterone and corticosterone values, and failure of pubertal progression.</Attribute>
              <Citation>
                <ID Source="PubMed">14715826</ID>
              </Citation>
              <XRef DB="OMIM" ID="202110" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYP17A1" />
          </GeneList>
          <Name>CYP17A1, IVS3AS, 4-BP DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">IVS3AS, 4-BP DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="609300.0035" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">17-@ALPHA-HYDROXYLASE/17,20-LYASE DEFICIENCY, COMBINED COMPLETE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5027666" SubmissionDate="2022-09-14" DateLastUpdated="2022-09-17" DateCreated="2022-09-17">
        <ClinVarSubmissionID localKey="NM_000102.3:c.667-13_667-10delTTTT|MedGen:C0001627" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002571920" DateUpdated="2022-09-17" DateCreated="2022-09-17" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">14715826</ID>
          </Citation>
          <Comment>Variant summary: CYP17A1 c.667-13_667-10delTTTT alters a non-conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. Several computational tools predict a significant impact on normal splicing: Three predict the variant weakens a 3' acceptor site. An impact on splicing due to the variant has been confirmed by studies which show the RT-PCR product of a homozygous patient lacked exon 4, which consists of 87 bp (29 amino acids), which is expected to keep the reading frame intact (Costa-Santos_2004). The variant was absent in 250138 control chromosomes. c.667-13_667-10delTTTT has been reported in the literature in one homozygous individuals affected with Congenital Adrenal Hyperplasia (Costa-Santos_2004). Additional functional studies have shown cells transfected with plasmids containing the intronic mutation did not express active protein (Costa-Santos_2004). One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. One laboratory classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYP17A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000102.3:c.667-13_667-10delTTTT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0001627" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12061022</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4275903" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="4887636|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002259179" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">14715826</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14715826</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14715826</ID>
          </Citation>
          <Comment>In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Studies have shown that this variant results in skipping of exon 4, but is expected to preserve the integrity of the reading-frame (PMID: 14715826). Experimental studies have shown that this variant affects CYP17A1 function (PMID: 14715826). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. This variant is also known as TTTT deletion. This variant has been observed in individual(s) with congenital adrenal hyperplasia (PMID: 14715826). This variant is not present in population databases (gnomAD no frequency). This sequence change falls in intron 3 of the CYP17A1 gene. It does not directly change the encoded amino acid sequence of the CYP17A1 protein. RNA analysis indicates that this variant induces altered splicing and likely results in a shortened protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYP17A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000010.10:g.104593889_104593892del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7867521" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000102.4:c.667-13_667-10del|OMIM:202110" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004215420" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000102.4:c.667-13_667-10del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="202110" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4275903" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7867521" TraitType="Disease" MappingType="XRef" MappingValue="202110" MappingRef="OMIM">
        <MedGen CUI="C0268285" Name="Deficiency of steroid 17-alpha-monooxygenase" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5027666" TraitType="Disease" MappingType="XRef" MappingValue="C0001627" MappingRef="MedGen">
        <MedGen CUI="C0001627" Name="Congenital adrenal hyperplasia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

